TBC1D30

Across TCGA pan-cancer cohorts, TBC1D30 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TBC1D30’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where TBC1D30 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TBC1D30 is over-expressed in tumor, although a few such as PDAC and LSCC show the opposite, repressed pattern.

PDAC, LUAD, and LSCC are the cancer types where TBC1D30 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TBC1D30 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	Female	All	−1.995	<.001	6	view →
LUAD	Male	II,III,IV	+0.540	<.001	6	view →
LSCC	Male	All	−0.359	.014	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

TBC1D30–PDAC

Open the PDAC breakdown →